TransMedics Group, Inc.
TMDX
$68.94
$0.090.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -71.52% | 1,436.87% | 476.83% | 186.26% | 110.56% |
| Total Depreciation and Amortization | 81.91% | 22.68% | 16.84% | 46.36% | 42.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 71.79% | -663.34% | 20.21% | 11.87% | 19.16% |
| Change in Net Operating Assets | 74.43% | 8.44% | 348.30% | 22,603.39% | -58.03% |
| Cash from Operations | 959.30% | 75.52% | 914.63% | 256.21% | 16.89% |
| Capital Expenditure | -35.58% | -14.02% | 84.18% | 61.81% | 38.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -35.58% | -14.02% | 84.04% | 61.81% | 38.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.80% | 161.30% | -51.93% | -33.38% | -4.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 24.24% | 161.30% | -53.69% | -33.38% | -4.93% |
| Foreign Exchange rate Adjustments | -191.34% | 113.68% | -97.67% | 1,404.84% | 306.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.22% | 238.50% | 300.87% | 621.49% | 40.56% |